Batch Effect Behind Species-Specific Results?

WIKIMEDIA, RAMALate last year, members of the Mouse ENCODE consortium reported in PNAS that, across a wide range of tissues, gene expression was more likely to follow a species-specific rather than tissue-specific pattern. For example, genes in the mouse heart were expressed in a pattern more similar to that of other mouse tissues, such as the brain or liver, than the human heart. But earlier this month, Yoav Gilad of the University of Chicago called these results into question on Twitter. With a dozen or so 140-character dispatches (including three heat maps), Gilad suggested the results published in PNAS were an anomaly—a result of how the tissue samples were sequenced in different batches. If this “batch effect” was eliminated, he proposed, mouse and human tissues clustered in a tissue-specific manner, confirming previous results rather than supporting the conclusions reported by the Mouse ENCODE team. “If you can contest a paper from just one tweet, that’s powerful,” said computational biologist Nicolas Robine of the New York Genome Center. “Of course people need the [reanalysis] to understand what they did, but [the tweet] seemed very clear.” Now, in a preprint published today (May 19) by F1000 Research, Gilad and his coauthor Orna Mizrahi-Man detailed how they reanalyzed the Mouse ENCODE data to reach this alternate conclusion. The researchers obtained raw data, analysis code, and other details from the Mouse ENCODE team. They then extracted information on when and how each sample was sequenced, and matched the human and mouse tissues to lanes on sequencing runs. Most of the samples, Gilad and Mizrahi-Man discovered, had been sequenced in batches clustered by species; mouse tissues were run in one batch, human tissues in another. Only one of five sequenced batches included tissues from both species, the researchers found. When Gilad and Mizrahi-Man applied statistical methods to eliminate this apparent batch effect, the species-specific clusters of gene expression disappeared. “When you correct for the batch effect, for the properties of how the study was designed, you do not see clustering by species,” said Gilad. “You see clustering by tissue.” Batch effects—the potential results of small differences between methods, machines, or individual experimenters that can influence experimental output—have been reported in several other studies. To avoid the issue, experiments are usually set up so that batch effects don’t overlap with biological variables. In this instance, said Gilad, including more runs with samples from both species may have proved helpful. With only four such samples, it’s unclear how effectively batch effects can be controlled for. Without more data, the conclusions of the Mouse ENCODE studies on species-specific gene expression are, to Gilad’s mind, uncertain at best. “It changes the entire conclusion, and argues that the conclusions of the Nature paper and PNAS paper are not warranted,” he told The Scientist. “At the very least, that there’s a question of whether a batch effect was responsible.” Steven Salzberg, a computational biologist at Johns Hopkins University in Baltimore who was not involved in the work, called the reanalysis “thorough, careful . . . and really quite convincing.” “The batch effect they uncovered undermines the results in a very serious way,” Salzberg told The Scientist. “I don’t think there’s any way to escape the fact that the main conclusion of the PNAS paper … is not true.” Along with Salzberg and Robine, several other researchers expressed little surprise at the results of Gilad and Mizrahi-Man’s reanalysis on Twitter. To many, these latest results echoed their own disbelief of those published last year. For example, Benoit Bruneau, a cardiovascular researcher at the Gladstone Institutes in San Francisco, wrote: “That’s a relief. Those papers baffled me. Now I know why.” To Robine, the issue at hand is a simple one. “If you have exceptional claims you need exceptional data,” he told The Scientist. “The main conclusions [of the PNAS paper] are probably wrong, but the experimental design was also not able to answer the question.” “The data was collected for a particular question or project,” he continued. “If you’re going to reanalyze the data for a different question, you have to see if your question is compatible with the way the data was collected.” Michael Snyder of Stanford University, a coauthor on the Mouse ENCODE study published in PNAS, is unconvinced by these latest results. “The reanalysis is really doing something we knew already,” he told The Scientist. “They wound up subtracting the species effect in the reanalysis, and therefore saw the tissue-specific effects, and that’s what we published as well.” Snyder added that although the samples were run on separate lanes, the experiments were all done at the same time by the same person. “Basically that eliminates the laboratory effect and the person effects. We’ve never seen lane effects ourselves, but we will now document that,” he told The Scientist. “The bottom line is that we are pretty confident in our results, and the fact that it was studied in many different labs. We’ve actually spent two years on this—it wasn’t some cursory thing.” To Snyder’s recollection, questions about potential batch effects were not raised during peer review of either of the Mouse ENCODE papers. The researchers did not participate in the Twitter discussion, which, as Snyder said, “can get personal—people start making negative comments about the authors very quickly.” “Social media is a great forum for other discussions, but not when you’re critiquing someone’s work in this format,” Snyder said, adding that he and his colleagues are planning an online response to the preprint, which has not yet been peer reviewed. Gilad was prompted to do the reanalysis because the published results “did not sit well with me,” he said. Because the results were reported by a consortium rather than a single investigator’s lab, he chose to share his findings via Twitter rather than more conventional means, such as contacting study authors or the journal. “We shared our analysis in the same way that the original data [was] shared—let the entire community figure it out,” he elaborated. Much like Snyder, Gilad was surprised by the lack of questions he received about his own work on Twitter. “I wasn’t surprised by how many people joined in the discussion, retweeted, and all that,” he said. “But I was surprised that no one said: ‘You can’t just share the headlines; this is science, you need to share the details.’” To integrative biologist Steve Phelps of the University of Texas at Austin, discussing experimental results in real time on Twitter is a bit unusual, but a reflection of how science is changing. “Overall, the reanalysis and the participation [from ENCODE researchers] is a pretty positive thing for science,” said Phelps. “The original authors made their data and sources publicly available and shared it readily. [Gilad and Mizrahi-Man] had concerns, and they were able to go into the data and come up with an alternative version.” “I think that [the discussion] is really pretty healthy and reflects well on both groups,” he added. O. Mizrahi-Man and Y. Gilad, “A reanalysis of mouse ENCODE comparative gene expression data,” F1000 Research, doi:10.12688/f1000research.6536.1, 2015.

Batch Effect Behind Species-Specific Results?

The Scientist ARCHIVES

Become a Member of

Related Topics

Meet the Author

Jyoti Madhusoodanan

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies